Therapy News and Research

RSS

Researchers examine hesitancy to use evidence-based treatment for childhood anxiety disorders

Both medication and a specific form of talk therapy called cognitive behavioral therapy (CBT) are proven evidence-based treatments for children and adolescents with anxiety disorders.

5 Dec 2022

Assisted living facilities pressed to address growing needs of older, sicker residents

Assisted living communities too often fail to meet the needs of older adults and should focus more on residents' medical and mental health concerns, according to a recent report by a diverse panel of experts.

5 Dec 2022

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Researchers evaluate the efficacy and safety of an oral antimicrobial drug acoziborole in patients with human African trypanosomiasis.

4 Dec 2022

Hepatitis B virus haplotype number is a predictive marker of functional cure during antiviral therapies

Patients with a lower hepatitis B virus haplotype number are more likely to achieve a functional cure with chronic hepatitis B treatment.

4 Dec 2022

AI could make doctors’ work simpler, faster, and more precise

One in nine women in the developed world will be diagnosed with breast cancer at some point in her life. The prevalence of breast cancer is increasing, an effect caused in part by the modern lifestyle and increased lifespans.

2 Dec 2022

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

In a new study, researchers assessed the neurodevelopment in preschool-aged Zika-exposed children without congenital Zika syndrome.

2 Dec 2022

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Researchers from the United States developed an affordable, non-invasive, inhalable prophylactic treatment consisting of immunoglobulin (Ig) A fused nanobodies against the SARS-CoV-2 Omicron variant.

2 Dec 2022

New tool may help better predict resistance to immunoglobulin therapy among children with Kawasaki disease

predict resistance to immunoglobulin therapy among children with Kawasaki disease in the United States.

2 Dec 2022

Laser light therapy effective in improving working memory

Laser light therapy has been shown to be effective in improving short term memory in a study published in Science Advances.

2 Dec 2022

Collaborative work unravels hidden molecular secrets of age-related diseases

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, and the University of Copenhagen announced today the release of the first batch of results from the collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and drug discovery pipeline.

2 Dec 2022

Study implicates gut microbiome health in Parkinson's disease

A new study published in the journal Nature Communications discusses the links between this condition that affects the brain and changes in the gut microbiome that may predate brain changes.

1 Dec 2022

Using cationic nanonmaterials to target visceral adiposity

Researchers have long been working on how to treat obesity, a serious condition that can lead to hypertension, diabetes, chronic inflammation, and cardiovascular diseases.

1 Dec 2022

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Previous infection with SARS-CoV-2 and booster vaccination protect against ICU admission and mortality following infection with the Omicron variant.

1 Dec 2022

Research shows biological sex as a crucial factor in the effectiveness of anti-aging drugs

The effect of medicines on women and men can differ significantly. This also applies to the currently most promising anti-aging drug rapamycin, as researchers from the Max Planck Institute for Biology of Ageing in Cologne and University College London have now shown.

1 Dec 2022

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn’s disease

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

1 Dec 2022

Discontinuation of opioid therapy for pain may increase overdose risk

Opioid-related overdose is now a leading cause of accidental death in the United States and Canada. A study published December 1st in the open access journal PLOS Medicine by Mary Clare Kennedy at University of British Columbia, Kelowna, Canada, and colleagues suggests discontinuing prescribed opioids was associated with increased overdose risk.

1 Dec 2022

Study implicates a specific type of brain cell as key player underlying the impact of stressors

More than 70% of adults will experience at least one traumatic experience, such as a life-threatening illness or accident, violent assault or natural disaster, in their lifetimes and nearly a third will experience four or more, according to global data.

1 Dec 2022

Newly identified genetic mutation may be a root cause of severe childhood glaucoma

An international team of scientists led by Mass Eye and Ear, a member of Mass General Brigham, and Boston Children's Hospital, has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, a devastating condition that runs in families and can rob children of their vision by 3 years of age.

1 Dec 2022

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Hiroshima University started the human trial for a promising treatment that offers hope in potentially reversing paralysis and language disorder after moderate to severe stroke using therapeutically superior mesenchymal stem cells (MSCs) derived from the cranial bone.

1 Dec 2022

Embracing Robotic Assistance in Neurorehabilitation

NewsMedical spoke to Waduda Parolari Musaid at MEDICA 2022 about Gloreha's robotics-assisted neurorehabilitation solutions. The robotic device and associated on-screen software suite aim to make hand movement recovery quicker and easier for patients.

From Gloreha 1 Dec 2022

Therapy News and Research

Researchers examine hesitancy to use evidence-based treatment for childhood anxiety disorders

Assisted living facilities pressed to address growing needs of older, sicker residents

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Hepatitis B virus haplotype number is a predictive marker of functional cure during antiviral therapies

AI could make doctors’ work simpler, faster, and more precise

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

New tool may help better predict resistance to immunoglobulin therapy among children with Kawasaki disease

Laser light therapy effective in improving working memory

Collaborative work unravels hidden molecular secrets of age-related diseases

Study implicates gut microbiome health in Parkinson's disease

Using cationic nanonmaterials to target visceral adiposity

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Research shows biological sex as a crucial factor in the effectiveness of anti-aging drugs

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn’s disease

Discontinuation of opioid therapy for pain may increase overdose risk

Study implicates a specific type of brain cell as key player underlying the impact of stressors

Newly identified genetic mutation may be a root cause of severe childhood glaucoma

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Embracing Robotic Assistance in Neurorehabilitation

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News